Redx Pharma is a drug discovery and development company formed in 2010. It is focused on improving the characteristics of existing drug classes to create best-in-class new drugs in the areas of cancer, infection and autoimmune disease. The company's work has been endorsed by partnerships with global pharmaceutical companies and the NHS.

Find out more

Latest News

Chancellor visits Redx labs
13 July 2015

Photo of George Osborne touring a Redx laboratory

The Chancellor George Osborne visited our Alderley Park site in Cheshire today, meeting staff and touring the laboratories within our anti-infectives business.

He used the occasion to announce the creation of a new Catapult in Medicines Technologies. Benefitting from £5m of funding, the new Centre will also be based at Alderley Park in Cheshire.

Read more

We're Hiring

As a fast-growing dynamic business we are continually looking for talented people to join our team.

Work for us

Admission to AIM

27 March 2015

Admission to AIM and First Dealings took place on Friday 27th March.

Investor Relations

Our Subsidiary Companies

Discovering and developing new therapeutics in the area of infectious disease generating a pipeline of novel antibacterial & antiviral drugs.

View details

Modulating the immune system with novel small molecules to treat a range of diseases with high unmet medical need.

View details

Applying our proprietary method to deliver multiple development candidates across a range of mechanistic approaches in cancer treatment.

View details